These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12771988)

  • 1. Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients.
    Nakashima T; Huang C; Liu D; Kameyama K; Masuya D; Kobayashi S; Kinoshita M; Yokomise H
    Br J Cancer; 2003 Jun; 88(11):1727-33. PubMed ID: 12771988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
    Ci H; Xu Z; Xu J; Wang Y; Wu S
    Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients.
    Masuya D; Huang C; Liu D; Nakashima T; Kameyama K; Haba R; Ueno M; Yokomise H
    Br J Cancer; 2004 Apr; 90(8):1555-62. PubMed ID: 15083185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
    Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
    Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.
    Stefanou D; Goussia AC; Arkoumani E; Agnantis NJ
    Anticancer Res; 2003; 23(6C):4715-20. PubMed ID: 14981918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer.
    Liu D; Huang C; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Yokomise H
    Ann Thorac Surg; 2001 Mar; 71(3):949-54; discussion 954-5. PubMed ID: 11269479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.
    Sulzer MA; Leers MP; van Noord JA; Bollen EC; Theunissen PH
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1319-23. PubMed ID: 9563756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of biological markers for treatments of resectable non-small-cell lung cancers.
    Huang C; Liu D; Masuya D; Nakashima T; Kameyama K; Ishikawa S; Ueno M; Haba R; Yokomise H
    Br J Cancer; 2005 Apr; 92(7):1231-9. PubMed ID: 15785747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.
    Jian WG; Darnton SJ; Jenner K; Billingham LJ; Matthews HR
    J Clin Pathol; 1997 Aug; 50(8):640-4. PubMed ID: 9301546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
    Szöke T; Kayser K; Trojan I; Kayser G; Furak J; Tiszlavicz L; Baumhäkel JD; Gabius HJ
    Eur J Cardiothorac Surg; 2007 May; 31(5):783-7. PubMed ID: 17369045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
    Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
    PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T; Huang CL; Liu D; Kameyama K; Masuya D; Ueno M; Haba R; Yokomise H
    Med Sci Monit; 2004 Jun; 10(6):BR157-65. PubMed ID: 15173661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
    Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
    Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.